Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorUniversity of New Mexico

About this trial

The purpose of this clinical trial is to investigate the effects of multiple sessions of transcranial direct current stimulation (tDCS) delivered while participants complete tasks that target social learning with high functioning adults with ASD and/or high traits of ASD.

The main question it aims to answer is:

What are the effects of multiple sessions of active compared to sham tDCS, with tDCS simultaneously paired with social learning tasks, from employing a within-subject, cross-over randomized controlled trial design?

Participants will:

* Complete a randomly assigned block of 5 sessions of active and a block of 5 sessions of sham tDCS, with a four-week break occurring between the two blocks. * Complete social learning tasks simultaneously during receipt of tDCS at each session (whether receiving active or sham tDCS). * Complete behavioral, physiological, and electrophysiological testing before and after each block of active or sham tDCS. * Complete a social validity questionnaire after completion of the study.

Eligibility criteria

Qualifiers

Age 18-35 years

Proficient in English

Classification of autism or autism spectrum disorder on Autism Diagnostic Observation Scale, 2nd Edition (ADOS-2) or score of >= 17 on Autism Quotient (AQ)

Good or corrected vision and hearing

Disqualifiers

No known loss of consciousness for > 5 minutes

No immediate biological family members with a history of epilepsy or seizure disorder

No major medical needs (e.g., neurological disorders such as a seizure disorder; long-term illness)

No surgically implanted metal above the neck (example: metal pins or plates, cochlear implants, aneurysm clips, brain electrodes)

Trial design

Treatments tested in this trial

  • Anodal tDCS + Social Learning
  • Placebo Anodal tDCS + Social Learning

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of New Mexico

Lead sponsor

National Institute of General Medical Sciences (NIGMS)

Collaborator